EcoDrugPlus

Ensembl ID : ENSOMYG00000025470
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSOMYG00000026697
Gene Symbol: -
Cross references: -
133 Possible Orthologues:

Ensembl ID : ENSOMYG00000026732
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSOMYG00000025191
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSOMYG00000025451
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSOMYG00000028934
Gene Symbol: -
1 Cross references
178 Possible Orthologues:

Ensembl ID : ENSOMYG00000027283
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSOMYG00000028729
Gene Symbol: -
Cross references: -
705 Possible Orthologues:

Ensembl ID : ENSOMYG00000027332
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSOMYG00000027364
Gene Symbol: RPS4X
1 Cross references
488 Possible Orthologues:

Ensembl ID : ENSOMYG00000028508
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSOMYG00000027397
Gene Symbol: -
Cross references: -
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).